Search
Search Results
##search.searchResults.foundPlural##
-
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1605PDF: 793HTML: 2182Untitled: 240Untitled: 210Untitled: 207Untitled: 218Untitled: 212 -
-
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1439PDF: 892HTML: 230 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4538PDF: 1513HTML: 8530 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1591PDF: 933HTML: 2008Figure: 189Tables: 201ALL revision 1: 287response to reviewer: 194 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1436PDF: 718HTML: 1184Untitled: 195Untitled: 160Untitled: 145Untitled: 164Untitled: 174 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2319PDF: 913HTML: 2013Fig 1 Rossi: 211 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2190PDF: 1590HTML: 650 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2515PDF: 1060HTML: 5107Cover Letter: 180Figure 2: 179Figure 1: 186Figure 3: 212Figure 4: 182Figure Legend: 196Table 1: 204Table 2: 197Table 3: 194 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1130PDF: 799HTML: 149 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1215PDF: 496HTML: 8249 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3579PDF: 1328HTML: 2056Fig.1: 228Fig. 2: 224 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3890PDF: 1708HTML: 11788Figures Haase: 225 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1268PDF: 620HTML: 2904ATRA induced Reactive Hemophagocytosis: A Case Report: 212 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3465PDF: 1321HTML: 2304Fi.1 Gritti.Rambaldi: 223 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4106PDF: 1573HTML: 9247Untitled: 292Untitled: 199Untitled: 184Untitled: 177Untitled: 199Untitled: 355 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
3007PDF: 1106HTML: 4675 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2111PDF: 789HTML: 3250 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2679PDF: 1657HTML: 2441Table1: 206 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1326PDF: 1101HTML: 245 -
Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma
1385PDF: 783HTML: 4410Figure 1: 175Untitled: 152Untitled: 203 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1590PDF: 579HTML: 865 -
Brain abscesses caused by Nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.
1747PDF: 1107HTML: 6557original file with images: 299 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
2002PDF: 899HTML: 7988Untitled: 209 -
Osteolytic bone lesions – A rare presentation of AML M6.
2039PDF: 1143HTML: 7982Untitled: 216 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2492PDF: 1625HTML: 693 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4051PDF: 1078HTML: 3893Untitled: 185Cneo. Fig.1: 122Untitled: 114Untitled: 142Untitled: 147 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8191PDF: 4373HTML: 7543 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1067PDF: 725HTML: 270







